Nelson, Van Denburg & Campbell Wealth Management Group, LLC Sangamo Therapeutics, Inc Transaction History

Nelson, Van Denburg & Campbell Wealth Management Group, LLC

$2.25 Billion
Q2 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2024 Apr 30, 2024	BUY	$0.42 - $1.38 $15 - $49	36 Added 7.64%	507 $0
Q4 2023 Jan 30, 2024	BUY	$0.3 - $0.63 $141 - $296	471 New	471 $0

Others Institutions Holding SGMO

# of Institutions

133

Shares Held

86.3M

Call Options Held

35.9K

Put Options Held

156K

Wasatch Advisors Inc Salt Lake City, UT

20.1M
Shares

$17.5 Million
0.04% of portfolio
Armistice Capital, LLC New York, NY

14.1M
Shares

$12.2 Million
0.07% of portfolio
Vanguard Group Inc Valley Forge, PA

11.9M
Shares

$10.4 Million
0.0% of portfolio
Black Rock Inc. New York, NY

4.7M
Shares

$4.09 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

4.56M
Shares

$3.97 Million
0.01% of portfolio

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $136M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nelson, Van Denburg & Campbell Wealth Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nelson, Van Denburg & Campbell Wealth Management Group, LLC with notifications on news.

Account